跳至主要内容
临床试验/NCT00863382
NCT00863382撤回不适用

Comparison of External Event Recorders With Implantable Monitor for Post Atrial Fibrillation Monitoring: Assessment of Cost and Efficacy

Dhanunjaya Lakkireddy, MD, FACC2 个研究点 分布在 1 个国家开始时间: 2009年1月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
2
主要终点
recurrence of atrial fibrillation

研究概览

简要总结

Ablation of atrial fibrillation is a well established treatment method to restore normal sinus rhythm and eliminate the need for continued antiarrhythmic therapy and anticoagulation. Absence of symptomatic and asymptomatic atrial fibrillation should be considered necessary for discontinuation of anticoagulation therapy. Presently, recurrence of atrial fibrillation is usually determined with the use of a non looping event monitor which is typically used by the subject at the time of symptomatic arrhythmia. This method does not detect asymptomatic atrial fibrillation. Random asymptomatic recording can be added, but the chance for detecting recurrence of arrhythmia is not great. Too frequently, the success rates of AF ablation procedures are inflated by insufficient follow up and patient's limited compliance in reporting and recording episodes of recurrent arrhythmias. Often times, it is very inconvenient for patients to wear external event recorders. Allergies to the sticky pads that are needed for most of the external monitoring devices continues to be a problem. Implantable loop recorders have the advantage of detecting symptomatic and asymptomatic atrial fibrillation continuously. They also offer the convenience of monitoring for up to 18 to 24 months without significant patient discomfort. However, implantation and explantation of these devices involves a limited surgical procedure as well as considerable experience. In this study we attempt to assess the differences in these two types of monitoring systems in assessing the long term efficacy of AF ablation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All subjects who undergo radiofrequency ablation of paroxysmal AF.

排除标准

  • Subjects with known allergy to sticky patches of event monitor
  • Subjects with skin infection or other problems on the chest that interferes with monitor implantation
  • Subjects who are scheduled for radiation therapy
  • Subjects who are scheduled for therapeutic ultrasound (like lithotripsy)
  • Subjects who are scheduled for MRI
  • Subjects who are scheduled for a procedure that uses diathermy.
  • Subjects, in the opinion of the investigator, are not suitable candidates for the study
  • Subjects that do not have analog telephone line at home.
  • Existing Cardiac Rhythm Management Device (e.g., pacemaker or ICD)

结局指标

主要结局

recurrence of atrial fibrillation

时间窗: 6 months, 1 year, 2 years

次要结局

  • cost-effectiveness ratio (ICER) between the two technologies and the 95% confidence interval for the ICER(6 months, 1 year, 2 years)
  • percentage of patients whose Coumadin is stopped prematurely due to inappropriate assumption of rhythm control(6 months, 1 year, 2 years)
  • percentage of patients who develop symptoms of stroke or transient ischemic attacks during follow up(6 months, 1 year, 2 years)
  • cost differences in follow up care between the two groups(6 months, 1 year, 2 years)

研究者

发起方
Dhanunjaya Lakkireddy, MD, FACC
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Dhanunjaya Lakkireddy, MD, FACC

Associate Professor of Medicine

University of Kansas Medical Center

研究点 (2)

Loading locations...

相似试验